Published in EMBO J on November 01, 1989
Structural basis of substrate specificity in the serine proteases. Protein Sci (1995) 4.22
The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J (1990) 2.19
QXP: powerful, rapid computer algorithms for structure-based drug design. J Comput Aided Mol Des (1997) 1.97
Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J (1990) 1.65
Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost (2007) 1.61
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A (1995) 1.58
The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J (1996) 1.56
Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest (1992) 1.54
The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J (1996) 1.53
Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem (2010) 1.48
Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci U S A (1991) 1.46
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J (1995) 1.45
Cellular consequences of thrombin-receptor activation. Biochem J (1996) 1.45
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci (1994) 1.44
Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A (1996) 1.44
Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity. Blood (2015) 1.42
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. Proc Natl Acad Sci U S A (1991) 1.35
Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost (2008) 1.35
Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proc Natl Acad Sci U S A (2012) 1.33
Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Proc Natl Acad Sci U S A (2005) 1.24
Crystal structure of wild-type human thrombin in the Na+-free state. Biochem J (2005) 1.18
Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery. Curr Drug Targets (2011) 1.15
Ixolaris: a factor Xa heparin-binding exosite inhibitor. Biochem J (2005) 1.14
Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes. J Biol Chem (2005) 1.14
Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci U S A (2004) 1.13
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1990) 1.13
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci (2004) 1.12
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol (2011) 1.12
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J (2000) 1.08
Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. J Biol Chem (2005) 1.07
Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J (1999) 1.07
Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1. J Biol Chem (2010) 1.07
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin. Proc Natl Acad Sci U S A (2003) 1.07
Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick. PLoS One (2008) 1.06
Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. J Biol Chem (2005) 1.06
Thrombin-aptamer recognition: a revealed ambiguity. Nucleic Acids Res (2011) 1.06
An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J Cell Biol (1991) 1.05
"Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure. J Clin Invest (1992) 1.04
The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. EMBO J (1997) 1.04
Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb Haemost (2009) 1.02
Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor. Protein Sci (1998) 1.00
Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro. Blood (2010) 1.00
Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin. Protein Sci (1998) 0.99
Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants. EMBO J (1997) 0.99
Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc Natl Acad Sci U S A (2008) 0.98
FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa. Biochem J (2007) 0.97
Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor. Biochemistry (2009) 0.96
Reaching the global minimum in docking simulations: a Monte Carlo energy minimization approach using Bezier splines. Proc Natl Acad Sci U S A (1998) 0.96
Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J (1993) 0.95
Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation. J Biol Chem (2005) 0.95
Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci (2007) 0.95
Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX. J Biol Chem (2005) 0.95
Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci U S A (2006) 0.94
Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium. J Mol Biol (2013) 0.93
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. Protein Sci (1993) 0.93
Structures of the tricorn-interacting aminopeptidase F1 with different ligands explain its catalytic mechanism. EMBO J (2002) 0.93
Partial characterization of vertebrate prothrombin cDNAs: amplification and sequence analysis of the B chain of thrombin from nine different species. Proc Natl Acad Sci U S A (1992) 0.93
The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly. J Biol Chem (2008) 0.93
Ionic interactions in the formation of the thrombin-hirudin complex. Biochem J (1991) 0.92
Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase. J Biol Chem (2008) 0.92
How Na+ activates thrombin--a review of the functional and structural data. Biol Chem (2008) 0.92
Cleavage of the thrombin receptor: identification of potential activators and inactivators. Biochem J (1996) 0.91
Molecular basis of thrombomodulin activation of slow thrombin. J Thromb Haemost (2009) 0.91
A critical role for thrombin in vertebrate lens regeneration. Philos Trans R Soc Lond B Biol Sci (2004) 0.90
Identification of the site of binding of sulfated, low molecular weight lignins on thrombin. Biochem Biophys Res Commun (2011) 0.90
Identification of a basic region on tissue factor that interacts with the first epidermal growth factor-like domain of factor X. Biochemistry (2007) 0.90
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding. Protein Sci (1997) 0.90
Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains. FEBS J (2006) 0.90
Macromolecular chelation as an improved mechanism of protease inhibition: structure of the ecotin-trypsin complex. EMBO J (1994) 0.89
Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors. PLoS One (2011) 0.89
Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Biochemistry (2011) 0.88
Thrombin-specific inhibition by and slow cleavage of hirulog-1. Biochem J (1992) 0.87
Correlated motions and residual frustration in thrombin. J Phys Chem B (2013) 0.87
Characterization of the heparin-binding site of the protein z-dependent protease inhibitor. Biochemistry (2012) 0.87
Meizothrombin is an unexpectedly zymogen-like variant of thrombin. J Biol Chem (2012) 0.86
Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin. J Cell Biochem (2012) 0.86
Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors. PLoS One (2012) 0.86
Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase. Thromb Haemost (2012) 0.85
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase. Proc Natl Acad Sci U S A (2000) 0.85
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A. Proc Natl Acad Sci U S A (1993) 0.85
Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex. Biochemistry (2009) 0.85
Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. Proc Natl Acad Sci U S A (1992) 0.85
Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries. PLoS One (2014) 0.85
Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci U S A (1992) 0.85
Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. J Biol Chem (2013) 0.84
Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen. Protein Sci (1994) 0.84
Factor VII mutant V154G models a zymogen-like form of factor VIIa. Biochem J (2003) 0.84
Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem (2014) 0.84
Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin. Protein Sci (1996) 0.84
Thrombin inhibition by serpins disrupts exosite II. J Biol Chem (2010) 0.83
Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building. Protein Sci (1996) 0.83
Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain. Biochem J (1992) 0.83
Interaction of activated protein C with serpins. Biochem J (1993) 0.83
Dynamics Govern Specificity of a Protein-Protein Interface: Substrate Recognition by Thrombin. PLoS One (2015) 0.82
Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa. J Biol Chem (2010) 0.81
Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells. Biochemistry (2012) 0.81
Protein inhibitors of proteinases. Annu Rev Biochem (1980) 7.76
The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem (1973) 4.24
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60
Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry (1983) 2.49
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J Mol Biol (1975) 2.24
D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. Thromb Res (1979) 2.09
Structure of alpha-chymotrypsin refined at 1.68 A resolution. J Mol Biol (1985) 2.08
Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone. Methods Enzymol (1981) 2.00
Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases. J Biol Chem (1982) 1.98
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81
Refined crystal structure of gamma-chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases. J Mol Biol (1981) 1.80
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
A comparison of the heme binding pocket in globins and cytochrome b5. J Biol Chem (1975) 1.74
Thrombin specificity. Ann N Y Acad Sci (1981) 1.55
Thrombin-cellular interactions. Ann N Y Acad Sci (1986) 1.47
Thrombin. Ann N Y Acad Sci (1986) 1.44
Structure of native porcine pancreatic elastase at 1.65 A resolutions. Acta Crystallogr B (1988) 1.38
Human alpha-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region. Biochemistry (1985) 1.22
Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem (1977) 1.21
Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci U S A (1986) 1.12
Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin. J Biol Chem (1984) 1.11
Amino acid sequence of human prothrombin fragments 1 and 2. Proc Natl Acad Sci U S A (1977) 1.08
Proflavin binding within the fibrinopeptide groove adjacent to the catalytic site of human alpha-thrombin. Biochemistry (1984) 1.07
Identification of regions of alpha-thrombin involved in its interaction with hirudin. Biochemistry (1987) 1.04
Localization of the binding site on fibrin for the secondary binding site of thrombin. Biochemistry (1988) 1.04
The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett (1983) 1.03
Exo-site affinity labeling of human thrombins. Similar labeling on the A chain and B chain/fragments of clotting alpha- and nonclotting gamma/beta-thrombins. J Biol Chem (1977) 1.01
The use of sequence-specific antibodies to identify a secondary binding site in thrombin. J Biol Chem (1988) 1.01
The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor. Eur J Biochem (1984) 0.99
The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett (1988) 0.99
Inhibited thrombins. Interactions with fibrinogen and fibrin. Biochem J (1987) 0.97
Enzymatic properties of proteolytic derivatives of human alpha-thrombin. Biochemistry (1988) 0.97
Staphylocoagulase-binding region in human prothrombin. J Biochem (1985) 0.97
Physical evidence for an apolar binding site near the catalytic center of human alpha-thrombin. Biochemistry (1977) 0.96
Preparation and characterization of proteolyzed forms of human alpha-thrombin. Thromb Res (1988) 0.95
Thrombin binding to the A alpha-, B beta-, and gamma-chains of fibrinogen and to their remnants contained in fragment E. J Biol Chem (1988) 0.94
Structure-function relationships in human alpha- and gamma-thrombins. Mol Cell Biochem (1984) 0.94
The structures and proteolytic specificities of autolysed human thrombin. Biochem J (1986) 0.93
Human D-Phe-Pro-Arg-CH2-alpha-thrombin crystallization and diffraction data. J Mol Biol (1989) 0.92
Inhibition of thrombin and trypsin by tripeptide aldehydes. Int J Pept Protein Res (1978) 0.92
The hirudin-binding site of human alpha-thrombin. Identification of lysyl residues which participate in the combining site of hirudin-thrombin complex. J Biol Chem (1989) 0.92
Mechanism of action of thrombin on fibrinogen. Reaction of the N-terminal CNBr fragment from the Aalpha chain of human fibrinogen with bovine thrombin. Arch Biochem Biophys (1974) 0.91
Interaction of thrombin with thrombomodulin. Ann N Y Acad Sci (1986) 0.90
Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII. Biochemistry (1987) 0.90
The mechanism of the fibrinogen-thrombin reaction. Thromb Res (1978) 0.90
Human thrombin: partial primary structure. Arch Biochem Biophys (1977) 0.89
Enzymic and nonenzymic properties of human beta-thrombin. J Biol Chem (1988) 0.88
Thrombin: active-site topography. Ann N Y Acad Sci (1986) 0.87
Mechanism of action of thrombin on fibrinogen. IV. Further mapping of the active sites of thrombin and trypsin. Arch Biochem Biophys (1974) 0.87
Thrombin interactions with cultured fibroblasts: relationship to mitogenic stimulation. Ann N Y Acad Sci (1986) 0.86
High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen. Biochemistry (1989) 0.82
Communication: An x-ray crystallographic study of thrombin. J Biol Chem (1974) 0.81
The oligosaccharide of human thrombin: investigations of functional significance. Blood (1984) 0.81
Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature (1998) 7.77
A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42
Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution. Nature (2012) 5.22
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet (1996) 4.62
Fourier Domain Mode Locking (FDML): A new laser operating regime and applications for optical coherence tomography. Opt Express (2006) 4.49
The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature (2000) 4.46
Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J Mol Biol (1984) 4.14
Proteasome from Thermoplasma acidophilum: a threonine protease. Science (1995) 3.62
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60
The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53
Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. Biochemistry (1987) 3.31
Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. J Mol Biol (1982) 3.28
Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem (1992) 3.27
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol (2003) 3.25
Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
The proteasome. Annu Rev Biophys Biomol Struct (1999) 3.13
Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00
Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94
Evidence for N- and C-terminal processing of a plant defense-related enzyme: Primary structure of tobacco prepro-beta-1,3-glucanase. Proc Natl Acad Sci U S A (1988) 2.86
Structure of the tetrameric restriction endonuclease NgoMIV in complex with cleaved DNA. Nat Struct Biol (2000) 2.82
Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster. Science (2001) 2.78
The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71
Structure and mechanism of the aberrant ba(3)-cytochrome c oxidase from thermus thermophilus. EMBO J (2000) 2.71
Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. J Mol Biol (1993) 2.66
The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci (1995) 2.63
Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry (1986) 2.52
Amplified, frequency swept lasers for frequency domain reflectometry and OCT imaging: design and scaling principles. Opt Express (2005) 2.48
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J (1988) 2.48
The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J (1990) 2.44
High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur J Biochem (1995) 2.44
X-ray crystallographic structure of the light-harvesting biliprotein C-phycocyanin from the thermophilic cyanobacterium Mastigocladus laminosus and its resemblance to globin structures. J Mol Biol (1985) 2.42
Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science (1994) 2.41
The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modelling and structural relationships. Eur J Biochem (1990) 2.37
X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem (1994) 2.37
The three-dimensional structure of class pi glutathione S-transferase in complex with glutathione sulfonate at 2.3 A resolution. EMBO J (1991) 2.36
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology (2001) 2.36
Kinetics of the inhibition of thrombin by hirudin. Biochemistry (1986) 2.33
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. J Mol Biol (1991) 2.19
Crystal structure of a thermostable type B DNA polymerase from Thermococcus gorgonarius. Proc Natl Acad Sci U S A (1999) 2.19
Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Structural homology of reaction centers from Rhodopseudomonas sphaeroides and Rhodopseudomonas viridis as determined by x-ray diffraction. Proc Natl Acad Sci U S A (1986) 2.16
Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14
Pyrobaculum aerophilum sp. nov., a novel nitrate-reducing hyperthermophilic archaeum. Appl Environ Microbiol (1993) 2.13
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J Mol Biol (1987) 2.06
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
alpha- and beta-forms of the 65-kDa subunit of protein phosphatase 2A have a similar 39 amino acid repeating structure. Biochemistry (1990) 2.03
Crystal structure of a DNA-dependent RNA polymerase (DNA primase). Nat Struct Biol (2001) 2.03
Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature (1992) 2.02
Tenascin: cDNA cloning and induction by TGF-beta. EMBO J (1988) 2.01
The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J (1991) 1.99
Structural and functional aspects of domain motions in proteins. CRC Crit Rev Biochem (1984) 1.99
The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution. Biochemistry (1975) 1.98
Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol (2002) 1.91
X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands. J Mol Biol (1989) 1.90
Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med (1996) 1.87
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85
Mistletoe therapy in oncology. Cochrane Database Syst Rev (2008) 1.84
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81
AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci U S A (1995) 1.80
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol (1977) 1.79
Crystal structure of the ATPase domain of translation initiation factor 4A from Saccharomyces cerevisiae--the prototype of the DEAD box protein family. Structure (1999) 1.79
Mutational studies on HslU and its docking mode with HslV. Proc Natl Acad Sci U S A (2000) 1.79
Comparison of two highly refined structures of bovine pancreatic trypsin inhibitor. J Mol Biol (1987) 1.77
Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. Science (1989) 1.76
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
Crystal structure of heat shock locus V (HslV) from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.75
Ultrahigh-speed optical coherence tomography imaging and visualization of the embryonic avian heart using a buffered Fourier Domain Mode Locked laser. Opt Express (2007) 1.75
Crystal structure of the xanthine oxidase-related aldehyde oxido-reductase from D. gigas. Science (1995) 1.74
Three-dimensional structure of class pi glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 A resolution. J Mol Biol (1992) 1.73
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. J Mol Biol (1973) 1.73
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc Natl Acad Sci U S A (1998) 1.72
Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide. J Biol Chem (1988) 1.72
Mitogen-activated 70K S6 kinase. Identification of in vitro 40 S ribosomal S6 phosphorylation sites. J Biol Chem (1991) 1.70
The crystal structure of dihydrodipicolinate synthase from Escherichia coli at 2.5 A resolution. J Mol Biol (1995) 1.70
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry (1991) 1.69
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
Coherent structural dynamics and electronic correlations during an ultrafast insulator-to-metal phase transition in VO2. Phys Rev Lett (2007) 1.67
Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors. Proc Natl Acad Sci U S A (1996) 1.66
cDNA cloning of porcine brain prolyl endopeptidase and identification of the active-site seryl residue. Biochemistry (1991) 1.66